ITV

Tag: MedLife

  • Ananth Narayanan joins Medlife as co-founder & CEO

    Ananth Narayanan joins Medlife as co-founder & CEO

    MUMBAI: The Board of Directors at Medlife, www.medlife.com, have announced that Mr. Ananth Narayanan (former CEO of Myntra and Jabong and ex McKinsey Senior Partner) would be joining the company as Co-Founder and CEO. In this capacity, Ananth will be responsible for driving the next S curve of growth, continue to strengthen the team, lead M&A’s, and help formulate strategy around new areas of growth. He will also be joining the Medlife Board of Directors.

    Medlife is the largest e-health company in India today with three business lines including pharmacy, diagnostics and e-consultation. Since its inception in November 2014 by Prashant Singh and Tushar Kumar, Medlife has scaled rapidly to become the first e-pharmacy to clock 1000-crore revenue run rate. It currently operates across 29 states, 4,000 cities and 25,000 pin codes in India fulfilling over 25,000 deliveries daily.

    Medlife operates its medicine delivery service through 40 fulfillment centers and 3 large regional hubs in 22 cities. It has one national and five regional laboratories and over 350 phlebotomists helping bring diagnostics to patients’ homes. It has also launched its e-consultation service after acquiring Eclinic247 last year.

    Speaking about this, Mr. Tushar Kumar and Mr. Prashant Singh, Founders, Medlife, said, “We are very excited to have Ananth partner with us in this journey. We look forward to working together to scale Medlife rapidly going forward. We are at a stage where we have to build this from a $200 million business to a $2 billion plus business over the next 5 years and Ananth in his previous stint has done just that.”

    Adding his comments, Mr. Ananth Narayanan, Co-Founder and CEO, Medlife said “Technology can play a disruptive role in making healthcare simple, personal, and accessible to all Indians. Medlife has built a terrific business and a great team. I look forward to working with them and with Prashant and Tushar to continue to scale the business.”

    This announcement comes on the heel of Medlife announcing the acquisition of Myra Medicines, India’s only express pharmacy delivery service. Post this acquisition Medlife now controls largest share of the e-pharmacy market, a space that is on way to become the next big disruptor after the food delivery service.

    Ananth Narayanan is the former Chief Executive Officer of Myntra. He led Myntra's aspiration to transform how people shop for fashion online and also focused on building category-leading fashion brands. Featured as one of ‘India's Hottest 40 under 40 Business Leaders’ in 2014, Ananth has deep expertise in driving performance improvement and has a particular passion for product development.

    Prior to joining Myntra, Ananth was a Director at Mckinsey & Company and worked with the firm for 15 years across four offices (Chicago, Shanghai, Taipei and Chennai). His role entailed leading the Product Development practice in Asia and working with companies on strategy, operations and organisation. He has successfully helped companies streamline operations and supply, improve product development, develop strategies, business plans and organisational models.

    Ananth has a Bachelor degree in Engineering from University of Madras and a Masters from the University of Michigan, in Industrial Engineering and Operations Research. He is on the Industry Advisory Board of University of Michigan’s Tauber Institute.

  • Medlife’s new campaign urges people to “Lafaddu Matt Bano”

    Medlife’s new campaign urges people to “Lafaddu Matt Bano”

    MUMBAI: Online healthcare platform, Medlife, is bolstering its marketing and communication efforts with a new campaign, ‘Lafaddu Lal’.

    The campaign aims to showcase the ease, comfort and convenience of ordering medicines online. Medlife’s unique features like monthly subscription for medicines are also presented in a light-hearted way. Through this campaign, Medlife continues to build on the brand promise of being ‘obsessed with health’, urging people to explore the convenience of an e-pharmacy or risk being labeled ‘Lafaddu Lal’!

    Medlife’s unique offerings include a 48-hour delivery promise with an assurance of ‘100% Genuine Medicines’. It also offers assured savings on medicines every time a person places an order on the app. It also has a subscription feature through which, consumers with a chronic illness can get their monthly refills on-time without the hassle of running around the pharmacies.

    This 360o campaign, conceived by Soho Square, Bengaluru, features actors Boman Irani and Varun Sharma as a comical father-son duo. Boman plays a father who is particular about his medication and Varun as his ‘Lafaddu’ son who keeps forgetting to order his dad’s medicines from Medlife.

    These humorous films are supported through print and outdoor mediums as well. They show the father-son duo in different scenarios to bring out various benefits and offerings, available on the Medlife app.

    Medlife International CEO Tushar Kumar says, “Both Boman and Varun bring in a dash of freshness to the brand and stand for everything that clearly defines the attributes of Medlife viz. New-age, energetic, cheerful, aspirational, innovative and consistent. We are really kicked up about this association and hope the journey ahead is going to be furthermore exciting.”

    Soho Square India chairman and chief creative officer Sumanto Chattopadhyay summarises the series of films as a chuckle-inducing campaign featuring a slightly sarcastic father and his bumbling son, help us deliver Medlife’s message in a memorable way.

    The consumer looks for availability, price and convenience and that’s what our film communicates in a light-hearted manner. Sarcasm and carelessness between a father and son is a very relatable behavior in the Indian context. Lafaddu Lal is the creative idea that binds the relationship. And, who better than Boman and Varun to play the characters!”

    The new ad campaign will be launched on the digital platform at the onset, followed by a strategic media plan for television, outdoor and print, to get the desired impact.

  • Soho Square wins creative mandate for Medlife

    Soho Square wins creative mandate for Medlife

    MUMBAI: Soho Square Bangalore has won the creative mandate for MedLife, the healthcare app. The agency has been awarded the reins of the account in the aftermath of a competitive multi-agency pitch. Soho Square will now partner with MedLife on a journey to simplify healthcare by making the entire experience a seamless process. The business will be handled out of the agency’s Bengaluru branch.

    MedLife brings together all stakeholders in the form of a single app-based platform, thereby providing customers with a smooth experience. The app promises to make healthcare delivery simple, accessible and affordable. From buying medicines to booking lab appointments, the MedLife app makes healthcare easy for customers. The brief from the client, meanwhile, was to communicate the ease of access to genuine medicine.

    MedLife CEO Tushar Kumar says, “We’ve always wanted our customer-facing communication to be easier, more joyous and for it to put a smile on faces. We wanted to drive home a short and simple communication to our potential customers that MedLife stands for the best ethics, best pharmacy practices, best service and most honest prices.”

    Soho Square India chairman & chief creative officer Sumanto Chattopadhyay adds, “It is exciting for us to work with one of the pioneer online pharmacies in India. We hope to play a role in helping them grow and prosper. While this is still a nascent category, it is one with tremendous potential; helping Medlife unlock this potential will be a very interesting journey for Soho Square.

    Given the size and volume of India, like any other consumer sector, the consumption in healthcare is huge. Only 1 per cent of the country buys medicine online. “With this opportunity ahead of us, our mandate is to create awareness and grow the category rapidly. The product on offer is truly advanced, which we believe has the potential to change the way India consumes medicine. This collaboration has already got us excited and we cannot wait to begin seeing what they have in store for us,” he adds.